Abiopharma

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Meeting

Signet Jewelers Announces Timing of Fiscal 2027 First Quarter Earnings Release and Conference Call

Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update

Intellia Therapeutics to Participate in Upcoming Investor Conferences

Valvoline Inc. Becomes the First Ronald McDonald House Global Corporate Partner Dedicated Solely to Funding Mental Health Initiatives

NEUPATH HEALTH TO REPORT Q1 2026 RESULTS AND HOST INVESTOR WEBINAR

Energy Transfer Reports First Quarter 2026 Results and Updates 2026 Financial Guidance

Sphere Entertainment Co. Reports First Quarter 2026 Results

Kura Oncology to Report First Quarter 2026 Financial Results